Radiation Oncology/Therapy: Page 442

Burdette acquires Tayman to build brachytherapy business
By AuntMinnie.com staff writers
Burdette Medical Systems is acquiring Tayman Medical, which manufactures a system for positioning of prostate radiation implants.
December 4, 2001
GE and Amersham to collaborate in PET
By AuntMinnie.com staff writers
GE Medical Systems and Amersham Health (formerly Nycomed Amersham Imaging) have inked a broad research agreement to develop new PET-based molecular diagnostic imaging technologies and systems.
November 29, 2001
Practice makes perfect in prostate brachytherapy
By Shalmali Pal
While permanent brachytherapy seed implantation has gained ground for the treatment of prostate cancer, a uniform standard of care is still in the works. In a presentation at the 2001 American Society for Therapeutic Radiology and Oncology meeting, Dr. Bradley Prestidge shared his group’s prostate brachytherapy plan.
November 20, 2001
Siemens Oncology signs deal with DxTx
By AuntMinnie.com staff writers
The Oncology Systems Group of Siemens Medical Solutions of Concord, CA, has signed an agreement with DxTx of Mountain View, CA, which is building a network of outpatient cancer screening and treatment centers.
November 19, 2001
ASRT to manage radiation oncology administrators
By AuntMinnie.com staff writers
The Society for Radiation Oncology Administrators has selected the American Society of Radiologic Technologists to manage its business operations, the ASRT said.
November 13, 2001
Draxis gets NRC approval for BrachySeed Pd-103
By AuntMinnie.com staff writers
Radiopharmaceutical manufacturer DraxImage has received final approval from the U.S. Nuclear Regulatory Commission for the palladium version of its BrachySeed brachytherapy implant.
November 12, 2001
Positron revenues slip
By AuntMinnie.com staff writers
PET manufacturer Positron reported third-quarter revenues of $356,000, down sharply from the $3.4 million posted in the third quarter of 2000.
November 11, 2001
Palatin raises $11 million
By AuntMinnie.com staff writers
Radiopharmaceutical developer Palatin Technologies has added $11 million to its war chest in a stock offering to a group of investment firms.
November 11, 2001
Radiation must be well targeted to prevent in-stent restenosis
By Shalmali Pal
SAN FRANCISCO - Of the 850,000 angioplasties performed in the U.S. this year, a great number of patients will develop recurrent symptoms due to in-stent restenosis. But the clinical outcome analysis from two START trials should help cement the efficacy of radiation therapy in stemming restenosis, according to a presentation at the American Society for Therapeutic Radiology and Oncology meeting.
November 8, 2001
ASTRO members take heart in San Francisco
By AuntMinnie.com staff writers
SAN FRANCISCO - The fear of flying, bridge threats, and the anthrax menace apparently failed to discourage people from attending the 43rd annual meeting of the American Society for Therapeutic Radiology and Oncology (ASTRO) meeting being held here this week.
November 7, 2001
Siemens introduces Primus Wizard
By AuntMinnie.com staff writers
Siemens Oncology Care Systems of Concord, CA, introduced a new oncology management workstation at this week's American Society for Therapeutic Radiology and Oncology (ASTRO) meeting in San Francisco.
November 7, 2001
Is fixed dosimetry in brachytherapy a prescription for trouble?
By Shalmali Pal
SAN FRANCISCO - The term "fixed dosimetry" may be a misnomer in that patients actually receive a wide range of radiation dose during intravascular brachytherapy, according to a presentation at the American Society for Therapeutic Radiology and Oncology meeting.
November 7, 2001
Previous Page
Page 442 of 464
Next Page